Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

F. Hoffmann-La Roche AG discovers HBV capsid inhibitors

May 4, 2017

Bristol-Myers Squibb presents apelin receptor agonists

May 4, 2017

French researchers present azaphenantrene analogues

May 3, 2017

Gruenenthal identifies Cav2.2 channel blockers

May 3, 2017

Agency for Science, Technology and Research (A*STAR) patents SMYD3 inhibitors

May 3, 2017

GlaxoSmithKline divulges BRD4 inhibitors

May 2, 2017

Bristol-Myers Squibb presents PD-L1/PD-1 and/or PD-L1/CD80 interaction inhibitors

May 2, 2017

Hetero Research Foundation identifies antiviral agents

May 2, 2017

Almirall discovers TRPA1 antagonists

May 2, 2017

Jiangsu Nhwaluokang Pharmaceutical Research & Development patents etomidate derivatives

May 2, 2017

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...